The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Xencor, Inc(NASDAQ:XNCR) 
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases in the United states and internationally. The company's product candidates include Obex...
Website: http://www.xencor.com
Founded: 1997
Full Time Employees: 166
Sector: Healthcare
Industry: Biotechnology
Xencor Days Payable Outstanding ttm (DPO)
Xencor Days Receivable Outstanding ttm (DSO)
Xencor Op Cashflow Per Share ttm
Xencor Free Cashflow Per Share ttm
Xencor Cash Per Share ttm
Xencor P/S ratio ttm
Xencor (GAAP) P/E ratio ttm
Xencor P/B ratio ttm
No extra charts and metrics for this ticker.